Marktgröße und Marktanteil von Therapeutika für neurologische Erkrankungen bis 2025 – 2031
Neurologic Disorders Therapeutics Market Report Analysis
Neurologic Disorders Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Biogen Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Novartis AG
- Pfizer Inc.
- Sage Therapeutics, Inc
- Boehringer Ingelheim International GmbH
- Bayer AG
- GlaxoSmithKline plc
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Indikation
- Parkinson-Erkrankungen
- Alzheimer-Erkrankungen
- psychotische Störungen
- epileptische Störungen
- Autismus-Erkrankungen
- Hirntumorerkrankungen
By Arzneimittelklasse
- ACE-Hemmer
- NMDA-Antagonist
- D2-Antagonisten
- andere
By Anwendung [Zentrales Nervensystem
- ZNS
- peripheres Nervensystem
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For